LANZAJET ANNOUNCES $47M IN NEW CAPITAL AND FIRST CLOSE OF EQUITY ROUND AT $650M PRE-MONEY VALUATION - FURTHER VALIDATING LANZAJET'S SAF TECHNOLOGY AND ENABLING GROWTH

LANZAJET ANNOUNCES $47M IN NEW CAPITAL AND FIRST CLOSE OF EQUITY ROUND AT $650M PRE-MONEY VALUATION - FURTHER VALIDATING LANZAJET'S SAF TECHNOLOGY AND ENABLING GROWTH

International Airlines Group (IAG), Shell, Groupe ADP, LanzaTech, and Mitsui make additional investments to support LanzaJet's growth and commercial deployment of its proprietary Alcohol-to-Jet (ATJ) technology CHICAGO, Feb. 19, 2026 /PRNewswire/ --...

Hanwha Ocean Signs Landmark Agreements to Strengthen Canada's Sovereign Defence Industrial Capacity, Expand Domestic Shipbuilding Workforce, and Accelerate Large-Scale Shipbuilding in Ontario

Hanwha Ocean Signs Landmark Agreements to Strengthen Canada's Sovereign Defence Industrial Capacity, Expand Domestic Shipbuilding Workforce, and Accelerate Large-Scale Shipbuilding in Ontario

Strategic MOU advances industrial capability and technology transfer in Ontario; trilateral LOI establishes an embedded shipbuilding workforce development and innovation hub HAMILTON, ON, Feb. 19, 2026 /PRNewswire/ -- Hanwha Ocean and Ontario...

Ericsson and Mastercard enhance global digital money movement and accelerate digital financial inclusion

Ericsson and Mastercard enhance global digital money movement and accelerate digital financial inclusion

Collaboration simplifies access to advanced money movement solutions for telecom service providers, fintechs and banks Strengthens digital ecosystems across emerging and developed markets Increases financial digital inclusion for unbanked and...

AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases

AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases

CAMBRIDGE, Mass., Feb. 10, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an...

CEVA ANNOUNCES STRATEGIC LEADERSHIP CHANGES IN ASIA-PACIFIC AND CHINA

CEVA ANNOUNCES STRATEGIC LEADERSHIP CHANGES IN ASIA-PACIFIC AND CHINA

LIBOURNE, France, Feb. 9, 2026 /PRNewswire/ -- Ceva Animal Health (Ceva), the world's fifth-largest animal health company operating in 110 countries, is implementing strategic organisational changes across Asia Pacific (APAC) and China to accelerate...

Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30

Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30

Positioning Telangana among the world's top five life sciences clusters by 2030 Targets USD 25 billion in investments Shifts focus from scale-led manufacturing to innovation-driven, value creation DAVOS, Switzerland, Jan. 22, 2026 /PRNewswire/ --...

China Has Unique Opportunity to Accelerate Textile and Apparel Decarbonization, New Research Finds

China Has Unique Opportunity to Accelerate Textile and Apparel Decarbonization, New Research Finds

Latest data from Apparel Impact Institute and Development Finance International highlights pathways for the world's biggest textile manufacturer to decarbonize its apparel sector Significant apparel footprint and robust climate infrastructure and...

Sisram Medical Partners with Sinmait Medical Technology to Build Next-Generation Manufacturing and Innovation Hub in China

Sisram Medical Partners with Sinmait Medical Technology to Build Next-Generation Manufacturing and Innovation Hub in China

HONG KONG, Jan. 21, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global wellness group offering Energy-Based Devices (EBD), injectables, and...

Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases treatment

Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases treatment

Insilico Medicine and Hygtia Therapeutics, an incubatee of Shenzhen Pengfu Fund of Fosun Health Capital and Fosun Pharma, have entered into an exclusive license and co-development collaboration to advance ISM8969 worldwide. Under the agreement, both...

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughput Kinase Inhibitor Screening

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughput Kinase Inhibitor Screening

HOUSTON, Jan. 20, 2026 /PRNewswire/ -- Sino Biological, Inc. is proud to announce the launch of its innovative SwiftFluo® TR-FRET Kinase Assay Kits, a ready-to-use, high-performance solution designed to accelerate kinase activity detection and...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 41
  • menu
    menu